Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any cone-rod dystrophy in which the cause of the disease is a mutation in the PROM1 gene.
Features include: Nyctalopia, Color vision defect, Abnormal light- and dark-adapted electroretinogram, and Reduced visual acuity and 3 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 1 | Color vision defect |
PROM1 function has not been fully characterized.
Cone-rod dystrophy 12 is associated with mutations in the PROM1 gene on chromosome 4.
Genetic testing for PROM1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for cone-rod dystrophy 12 has been reported in the published literature.
No clinical trials have been registered for cone-rod dystrophy 12.
24 publications have been identified in PubMed for cone-rod dystrophy 12. Research spans Epidemiology / Natural History (29%), Case Report / Case Series (25%), and Basic Science / Preclinical (21%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 7 | 29% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:00 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about cone-rod dystrophy 12
Patient case studies
6 |
25% |
Laboratory research | 5 | 21% |
New treatment approaches | 3 | 13% |
Other research | 1 | 4% |
Testing and diagnosis research | 1 | 4% |
Research summaries | 1 | 4% |
Bhattacharya S (2026). [PMID: 42193986](https://pubmed.ncbi.nlm.nih.gov/42193986/). *Biomolecules*. [Review / Meta-Analysis]
Varughese RS (2026). [PMID: 42044156](https://pubmed.ncbi.nlm.nih.gov/42044156/). *J Clin Endocrinol Metab*. [Other]
Li M (2025). [PMID: 41381383](https://pubmed.ncbi.nlm.nih.gov/41381383/). *Molecular genetics & genomic medicine*. [Case Report / Case Series]
Uner OE (2025). [PMID: 39763288](https://pubmed.ncbi.nlm.nih.gov/39763288/). *Ophthalmic genetics*. [Epidemiology / Natural History]
Ji H (2025). [PMID: 41211702](https://pubmed.ncbi.nlm.nih.gov/41211702/). *FASEB journal : official publication of the Federation of American Societies for Experimental Biology*. [Gene Therapy / Novel Therapeutics]
Holland J (2025). [PMID: 41091173](https://pubmed.ncbi.nlm.nih.gov/41091173/). *Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie*. [Epidemiology / Natural History]
Demas N (2025). [PMID: 40877827](https://pubmed.ncbi.nlm.nih.gov/40877827/). *BMC medical genomics*. [Diagnostic / Biomarker]
Kick GR (2025). [PMID: 41295716](https://pubmed.ncbi.nlm.nih.gov/41295716/). *Veterinary sciences*. [Case Report / Case Series]
Shinkawa K (2025). [PMID: 40720941](https://pubmed.ncbi.nlm.nih.gov/40720941/). *Nephron*. [Case Report / Case Series]
D'Esposito F (2025). [PMID: 41300751](https://pubmed.ncbi.nlm.nih.gov/41300751/). *Genes*. [Basic Science / Preclinical]